Articles by Doug Roe
-
Insiders' Guide To Winning In The Drug Delivery Device Market — Part 4: Vertical Integration
2/23/2016
The tenets of vertical integration can drive a complete combination product development strategy, as well as establish the internal core competencies needed to consistently execute that strategy. I recently sat down with Anand Subramony, VP of drug delivery and device development at Medimmune (the global biologics arm of AstraZeneca). We discussed his thoughts on trends in the drug delivery device market and how the business philosophies of vertical integration can play a role.
-
Insiders' Guide To Winning In the Drug Delivery Device Market — Part 3: Quality Systems
2/9/2016
I recently sat down with Christopher Eustace of Hospira, who has over 27 years of quality experience in both the pharmaceutical and medical device industries, to discuss how a combined QS program is necessary for life science companies striving to capture their piece of the delivery device market.
-
Insiders' Guide To Winning In the Drug Delivery Device Market — Part 2: Regulatory Compliance
1/26/2016
I recently sat down with David Amor, managing partner at MEDgineering, Inc., to discuss the challenges associated with bringing drug delivery devices to market, as well as emerging therapeutic areas and technologies. David’s background is in mechanical and biomedical engineering, with expertise in regulatory systems and compliance.
-
Insiders' Guide To Winning In the Drug Delivery Device Market — Part 1: Design
1/12/2016
As challenges continue to mount in the med device industry, many companies are looking to drug delivery as a new revenue stream. Here, Neil Cammish, technical director, International Device Solutions, discusses the drug delivery technologies poised to have a market impact in 2016 and beyond.